| Applications: |
Immunodepletion/Immunocompetition |
| Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Short Description: |
Dopamine Receptor D3 Blocking Peptide for STJ500716 is synthetically produced from the sequence and is suitable for use in western blot applications. |
| Formulation: |
Liquid form at 2.5mg/ml concentration in PBS. Up to 5% DMSO can be added. Orders with >1mg can be supplied in lyophilized powder form, or in buffer of choice. |
| Storage Instruction: |
Store at-20°C for long term storage. Avoid freeze-thaw cycles. |
| Gene Symbol: |
Drd3 |
| Gene ID: |
29238 |
| Uniprot ID: |
DRD3_RAT |
| Specificity: |
This blocking peptide is recommended for use in combination with Dopamine Receptor D3 antibody, STJ500716 |
| Immunogen: |
Synthetic peptide corresponding to unique amino acid sequence on Dopamine Receptor D3 protein, peptide was covalently modified. Sequence: CQACHVSPELYRATTWGY |
| Tissue Specificity | Mainly in limbic areas of brain. |
| Post Translational Modifications | Phosphorylated by GRK4. Palmitoylated. |
| Function | Dopamine receptor whose activity is mediated by G proteins which inhibit adenylyl cyclase. Promotes cell proliferation. |
| Peptide Name | D(3 Dopamine ReceptorDopamine D3 Receptor |
| Database Links | Reactome: R-RNO-390651Reactome: -RNO-418594 |
| Cellular Localisation | Cell MembraneMulti-Pass Membrane Protein |
| Alternative Peptide Names | D(3 Dopamine Receptor proteinDopamine D3 Receptor proteinDrd3 protein |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance
